Determinants of COVID-19 vaccine acceptance in a high infection-rate country: a cross-sectional study in Russia

Van D Tran¹, Tatiana V Pak², Elena I Gribkova³, Galina A Galkina⁴, Ekaterina E Loskutova⁵, Valeria V Dorofeeva⁶, Rebecca S Dewey⁷, Kien T Nguyen⁸, Duy T Pham⁹

Affiliations

¹ Department of Drug Administration, Faculty of Pharmacy & Department of Traditional Medicine, Faculty of Medicine, Can Tho University of Medicine and Pharmacy. Can Tho (Vietnam). tvde@ctump.edu.vn.
² Department of Management and Economics of Pharmacy, Faculty of Medicine, Peoples' Friendship University of Russia (RUDN University). Moscow (Russia). pak-tv@rudn.ru.
³ Department of Management and Economics of Pharmacy, Faculty of Medicine, Peoples' Friendship University of Russia (RUDN University). Moscow (Russia). gribkova-ei@rudn.ru.
⁴ Department of Management and Economics of Pharmacy, Faculty of Medicine, Peoples' Friendship University of Russia (RUDN University). Moscow (Russia). gg-2005@mail.ru.
⁵ Department of Management and Economics of Pharmacy, Faculty of Medicine, Peoples' Friendship University of Russia (RUDN University). Moscow (Russia). loskutova-ee@rudn.ru.
⁶ Department of Management and Economics of Pharmacy, Faculty of Medicine, Peoples' Friendship University of Russia (RUDN University). Moscow (Russia). dorofeeva_vv@rudn.ru.
⁷ Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham. Nottingham (United Kingdom). Rebecca.Dewey@nottingham.ac.uk.
⁸ Department of Physiology, Faculty of Medicine, Can Tho University of Medicine and Pharmacy. Can Tho (Vietnam). ntkien@ctump.edu.vn.
⁹ Department of Chemistry, College of Natural Sciences, Can Tho University. Can Tho (Vietnam). pdtoan@ctu.edu.vn.

PMID: 33828622
PMCID: PMC8005327
DOI: 10.18549/PharmPract.2021.1.2276

Determinants of COVID-19 vaccine acceptance in a high infection-rate country: a cross-sectional study in Russia

Van D Tran et al. Pharm Pract (Granada). 2021 Jan-Mar.

. 2021 Jan-Mar;19(1):2276.

doi: 10.18549/PharmPract.2021.1.2276. Epub 2021 Mar 22.

Authors

Van D Tran¹, Tatiana V Pak², Elena I Gribkova³, Galina A Galkina⁴, Ekaterina E Loskutova⁵, Valeria V Dorofeeva⁶, Rebecca S Dewey⁷, Kien T Nguyen⁸, Duy T Pham⁹

Affiliations

¹ Department of Drug Administration, Faculty of Pharmacy & Department of Traditional Medicine, Faculty of Medicine, Can Tho University of Medicine and Pharmacy. Can Tho (Vietnam). tvde@ctump.edu.vn.
² Department of Management and Economics of Pharmacy, Faculty of Medicine, Peoples' Friendship University of Russia (RUDN University). Moscow (Russia). pak-tv@rudn.ru.
³ Department of Management and Economics of Pharmacy, Faculty of Medicine, Peoples' Friendship University of Russia (RUDN University). Moscow (Russia). gribkova-ei@rudn.ru.
⁴ Department of Management and Economics of Pharmacy, Faculty of Medicine, Peoples' Friendship University of Russia (RUDN University). Moscow (Russia). gg-2005@mail.ru.
⁵ Department of Management and Economics of Pharmacy, Faculty of Medicine, Peoples' Friendship University of Russia (RUDN University). Moscow (Russia). loskutova-ee@rudn.ru.
⁶ Department of Management and Economics of Pharmacy, Faculty of Medicine, Peoples' Friendship University of Russia (RUDN University). Moscow (Russia). dorofeeva_vv@rudn.ru.
⁷ Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham. Nottingham (United Kingdom). Rebecca.Dewey@nottingham.ac.uk.
⁸ Department of Physiology, Faculty of Medicine, Can Tho University of Medicine and Pharmacy. Can Tho (Vietnam). ntkien@ctump.edu.vn.
⁹ Department of Chemistry, College of Natural Sciences, Can Tho University. Can Tho (Vietnam). pdtoan@ctu.edu.vn.

PMID: 33828622
PMCID: PMC8005327
DOI: 10.18549/PharmPract.2021.1.2276

Abstract

Background: COVID-19 vaccine development is proceeding at an unprecedented pace. Once COVID-19 vaccines become widely available, it will be necessary to maximize public vaccine acceptance and coverage.

Objective: This research aimed to analyze the predictors of COVID-19 vaccine acceptance in Russia.

Methods: A cross-sectional online survey was conducted among Russian adults from September 26^th to November 9^th, 2020. Predictors of the intent to take up COVID-19 vaccination were explored using logistic regression.

Results: Out of 876 participants, 365 (41.7%) would be willing to receive the vaccine if it became available. Acceptance increased for a vaccine with verified safety and effectiveness (63.2%). Intention to receive the COVID-19 vaccine was relatively higher among males (aOR=2.37, 95% CI 1.41-4.00), people with lower monthly income (aOR=2.94, 95%CI 1.32-6.57), and with positive trust in the healthcare system (aOR=2.73, 95% CI 1.76-4.24). The Russian people were more likely to accept the COVID-19 vaccine if they believed that the vaccine reduces the risk of virus infection (aOR=8.80, 95%CI 5.21-14.87) or relieves the complications of the disease (aOR=10.46, 95%CI 6.09-17.96). Other barriers such as being unconcerned about side-effects (aOR=1.65, 95%CI 1.03-2.65) and the effectiveness and safety of the vaccination (aOR=2.55, 95%CI 1.60-4.08), also affected acceptance.

Conclusions: The study showed the usefulness of the health belief model constructs in understanding the COVID-19 vaccination acceptance rate in the Russian population. This rate was influenced by sociodemographic and health-related characteristics, and health beliefs. These findings might help guide future efforts for policymakers and stakeholders to improve vaccination rates by enhancing trust in the healthcare system.

Keywords: Attitude; Attitudes; COVID-19; COVID-19 Vaccines; Health Knowledge; Immunization Programs; Multivariate Analysis; Pandemics; Practice; Russia; SARS-CoV-2; Surveys and Questionnaires; Vaccination; Vaccination Refusal.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST None.

Figures

**Figure 1. Proportion of respondents agreeing with health belief model constructs (N = 876)**

See this image and copyright information in PMC

Cited by

COVID-19 Vaccine Hesitancy in Italy: Predictors of Acceptance, Fence Sitting and Refusal of the COVID-19 Vaccination.
Zarbo C, Candini V, Ferrari C, d'Addazio M, Calamandrei G, Starace F, Caserotti M, Gavaruzzi T, Lotto L, Tasso A, Zamparini M, de Girolamo G. Zarbo C, et al. Front Public Health. 2022 Apr 29;10:873098. doi: 10.3389/fpubh.2022.873098. eCollection 2022. Front Public Health. 2022. PMID: 35570888 Free PMC article.
Association between health and safety perceptions of COVID-19 vaccine and its uptake in Ghana.
Aram SA, Hagan JE Jr, Mansoh GKA, Saalidong BM, Lartey PO, Ahinkorah BO, Seidu AA, Ameyaw EK, Appiah A, Hotor DW, Gyimah J. Aram SA, et al. Public Health Chall. 2022 Dec;1(4):e20. doi: 10.1002/puh2.20. Epub 2022 Oct 13. Public Health Chall. 2022. PMID: 37519313 Free PMC article.
Prevalence and determinants of COVID-19 vaccine acceptance among vulnerable populations in Thailand: An application of the health belief model.
Rukchart N, Hnuploy K, Eltaybani S, Sonlom K, Chutipattana N, Le CN, Patthanasak Khammaneechan, Jongjit W, Supaviboolas S. Rukchart N, et al. Heliyon. 2024 Feb 12;10(4):e26043. doi: 10.1016/j.heliyon.2024.e26043. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38384553 Free PMC article.
Acceptance of COVID-19 vaccine and its related determinants in Nigeria: An online survey.
Ezigbo ED, Enitan SS, Adejumo EN, Durosinmi AE, Akele RY, Dada MO, Itodo GE, Idoko AM, Edafetanure-Ibeh OM, Okafor EN, Abdulsalam AA, Oyedoyin OI, Yelpoji PU, Opeyemi OO, Nmesomachi OS, Oyekale AO, Onyeji CB. Ezigbo ED, et al. World J Virol. 2024 Dec 25;13(4):98551. doi: 10.5501/wjv.v13.i4.98551. World J Virol. 2024. PMID: 39722760 Free PMC article.
Predicting COVID-19 vaccination uptake in Armenia using the Health Belief Model: Results from a nationwide survey.
Harutyunyan T, Sargsyan Z, Sahakyan S, Chiloyan A, Melkom Melkomian D, Khachadourian V. Harutyunyan T, et al. Hum Vaccin Immunother. 2023 Dec 31;19(1):2165383. doi: 10.1080/21645515.2023.2165383. Epub 2023 Jan 23. Hum Vaccin Immunother. 2023. PMID: 36688424 Free PMC article.

See all "Cited by" articles

References

1. Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019:a model-based analysis. Lancet Infect Dis. 2020;20(6):669–677. doi: 10.1016/s1473-3099(20)30243-7. - DOI - PMC - PubMed
1. Weekly operational update on COVID-19 - 30 November 2020. [accessed Mar 10 2021]. https://www.who.int/publications/m/item/weekly-operational-update---30-n... .
1. Chhetri JK, Chan P, Arai H, et al. Prevention of COVID-19 in Older Adults:A Brief Guidance from the International Association for Gerontology and Geriatrics (IAGG) Asia/Oceania region. J Nutr Health Aging. 2020;24(5):471–472. doi: 10.1007/s12603-020-1359-7. - DOI - PMC - PubMed
1. Lim WS, Liang CK, Assantachai P, et al. COVID-19 and older people in Asia:Asian Working Group for Sarcopenia calls to actions. Geriatr Gerontol Int. 2020;20(6):547–558. doi: 10.1111/ggi.13939. - DOI - PMC - PubMed
1. Harapan H, Wagner AL, Yufika A, et al. Acceptance of a COVID-19 Vaccine in Southeast Asia:A Cross-Sectional Study in Indonesia. Front Public Health. 2020;8:381. doi: 10.3389/fpubh.2020.00381. - DOI - PMC - PubMed

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Determinants of COVID-19 vaccine acceptance in a high infection-rate country: a cross-sectional study in Russia

Affiliations

Determinants of COVID-19 vaccine acceptance in a high infection-rate country: a cross-sectional study in Russia

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous